Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients

BLOOD

AMER SOC HEMATOLOGY

1. National Cancer Institute, National Institutes of Health [R01 CA205954]
2. Leukemia and Lymphoma Society
3. International Waldenstrom Macroglobulinemia Foundation
4. Michele & Stephen Kirsch Fund for Waldenstrom Macroglobulinemia
5. NATIONAL CANCER INSTITUTE [R01CA205954] Funding Source: NIH RePORTER